Sana Biotechnology, Inc. (SANA) Tops Q1 EPS by 3c

Sana Biotechnology, Inc. (NASDAQ: SANA) reported Q1 EPS of ($0.21), $0.03 better than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Sana Biotechnology, Inc. (SANA) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Desjardins Downgrades Alithya Group Inc. (ALYA:CN) (ALYA) to Hold
• Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Tops Q2 EPS by 24c